TradeWorx’s Bristol-Myers Squibb BMY Stock Holding History

TradeWorx’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-22,412	Closed	-$1M	–	425
2013 Q2	$1M	Buy	+22,412	New	+$973K	0.43%	46

Other funds holding BMY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TradeWorx's BMY Position: Q3 2013 in Review

TradeWorx sold out of Bristol-Myers Squibb (BMY) in Q3 2013, closing a stake of 22,412 shares — an estimated $1M sold.

TradeWorx first reported a position in BMY in Q2 2013 and held it in 1 quarter. The position peaked at $1M in Q2 2013. 1,187 funds tracked by Wall St. Rank hold BMY as of Q3 2013.

TradeWorx reported no remaining Bristol-Myers Squibb position as of Q3 2013 after selling out during the quarter.
TradeWorx sold 22,412 Bristol-Myers Squibb shares in Q3 2013, an estimated $1M.
TradeWorx first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 1 quarter.
TradeWorx's Bristol-Myers Squibb position peaked at $1M in Q2 2013.
1,187 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2013.

Based on TradeWorx's 13F filing for Q3 2013, filed 15 Nov 2013.